(TTA)n repeat polymorphism in the HMG-CoA reductase gene and cholesterolaemia

Vasa - Journal of Vascular Diseases

Volumn 28, Issue 3, 1999, Pages 169-171

  Hubacek, Jaroslav A ^a   Pistulkova H ^a   Valenta, Z ^a   Poledne, R ^a  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

Cholesterolaemia; HMG CoA reductase

Indexed keywords

ADENINE; CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LIPID; THYMINE;

ALLELE; ALU SEQUENCE; ARTICLE; ATHEROSCLEROSIS; CHILD; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; RISK FACTOR;

EID: 0032797545     PISSN: 03011526     EISSN: None     Source Type: Journal    
DOI: 10.1024/0301-1526.28.3.169     Document Type: Article

References (21)

1. Hamada H, Petrino M, Kakunaga T. A novel repeated element with Z-DNA forming potential is widely found in evolutionarily diverse eucariotic genomics. Proc Natl Acad Sci USA 1982; 79: 6465-6469.
2. Hubacek JA, Pistulková H, Pìša Valenta Z, Škodová Z, Poledne R. Lack of an association between apolipoprotein B XbaI polymorphism and blood lipid parameters in childhood. Physiol Res 1998; 47: 89-93.
3. Humphries SE, Tata F, Henry I, Barichard F, Holm M, Junien C, Williamson R. The isolation, characterisation, and chromosomal assignment of the gene for human 3-hydroxy-methylglutaryl-coenzyme A reductase, (HMG-CoA reductase). Hum Genet 1985; 71: 254-258.
4. Humphries SE, Panahloo A, Montgomery HE, Green F, Yudkin J. Gene-environment interaction in the determination of levels of haemostatic variables involved in thrombosis and fibrinolysis. Thromb Haemost 1997; 78: 457-461.
5. Leitersdorf E, Hwang M, Luskey KL. ScrFI polymorphism in the 2nd intron of the HMGCR gene. Nucleic Acid Res 1990; 18: 5584.
6. Leitersdorf E, Luskey KL. HgiAI polymorphism near the HMGCG promoter. Nucleic Acid Res 1990; 18: 5584.
7. Lindgren V, Luskey KL, Russell DW, Francke U. Human genes involved in cholesterol metabolism: chromosomal mapping of the low density lipoprotein receptor and 3-hydroxymethylglutaryl-coenzyme A reductase with cDNA probes. Proc Natl Acad Sci USA 1985; 24: 8567-8571.
8. Litt M, Luty JA. A hyper-variable microsatellite revealed by in vitro amplification of a dinucleotide repeat within the cardiac muscle actin gene. Am J Hum Genet 1989; 44: 397-401.
9. Logan RL, Thomson M, Riemersma RA, Oliver MF. Risk factors for ischaemic heart disease in normal men aged. 40 - Edinburgh - Stockholm Study. Lancet 1978; (I): 949-954.
10. Lusis AJ. Genetic factors affecting blood lipoproteins: the candidate gene approach. J Lipid Res 1988; 29: 397-429.
11. Miesfeld R, Krystal M, Arnheim N. A member of a new repeated sequence family which is conserved throughout eucaryotic evolution is found between the human gamma-and beta-globin genes. Nucleic Acids Res 1981; 9: 5931-5947.
12. Miettinen TA. Impact of apo E genotype on the regulation of cholesterol metabolism. Ann Med 1991; 23: 181-186.
13. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extraction DNA from human nucleated cells. Nucleic Acid Res 1988; 16: 1215.
14. Pedersen JC, Berg K. Interaction between the low density lipoprotein receptor (LDLR) and apolipoprotein E (apoE) alleles contributes to normal variation in lipid level. Clin Genet 1989; 35: 331-337.
15. Pedersen JC, Berg K. Gene-gene interaction between the low density lipoprotein receptor and apolipoprotein E loci affects lipid levels. Clin Genet 1990; 38: 287-294.
16. Pistulková H, Poledne R, Kaucká J, Škodová Z, Petržílková Z, Paclt M, Valenta Z, Grafnetter D, Píša Z. Cholesterolaemia in school-age children and hypercholesterolaemia aggregation in the family. Cor Vas 1991; 33: 139-149.
17. Poledne R, Hubacek J, Píša Z, Pistulková H, Valenta Z. Genetic markers in hypercholesterolaemic and normocholesterolaemic Czech children. Clin Genet 1994; 46: 88-91.
18. Porkka KVK, Taimela S, Kontula K, Lehtimäki T, Aalto Setälä K, Äkerblom HK, Viikari JSA: Variability gene effects of DNA polymorphisms at the apo B, apo AI/CIII and apo E loci on serum lipids: the Cardiovascular Risk in Young Finns Study. Clin Genet 1994; 45: 113-121.
19. Schmid CW, Jelinek RW. The Alu family of dispersed repetitive sequences. Science 1982; 216: 1065-1070.
20. Stamler J. Lifestyles, major risk factors, proof and public policy. Circulation 1978; 58: 3-19.
21. Zuliani G, Hobbs HH. A high frequency of length polymorphisms in repeated sequences adjacent to Alu sequences. Am J Hum Genet 1990; 46: 963-969.